Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain wave study aims to decode Ketamine's impact on tough depression

NCT ID NCT07307768

First seen Jan 07, 2026 · Last updated May 20, 2026 · Updated 22 times

Summary

This study will test whether brain wave (EEG) patterns can serve as a marker for how ketamine affects depression symptoms. Twenty adults with treatment-resistant depression will receive ketamine infusions while researchers monitor their brain activity and mood changes. The goal is to better understand ketamine's effects, not to provide treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION (TRD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Columbia University Irving Medical Center

    New York, New York, 10032, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.